Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study-Reference-Cited by-同舟云学术

Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study

Published:2017-12-05 Issue:5 Volume:33 Page:507-512
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Zhao Linru, ,Zhao Zhiqiang,Chen Xiaolu,Li Jingyue,Liu Jinping,Li Guangping

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s00380-017-1097-x/fulltext.html

Reference18 articles.

1. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):e362–e425

2. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20

3. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa UM, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2015) 2014 ESC/EACTS guidelines on myocardial revascularization. Eurointervention 10(9):1024–1094

4. Bell WR (2002) Present-day thrombolytic therapy: therapeutic agents—pharmacokinetics and pharmacodynamics. Rev Cardiovasc Med 3(Suppl 2):S34–S44

5. Ohman EM, Harrington RA, Cannon CP, Agnelli G, Cairns JA, Kennedy JW (2001) Intravenous thrombolysis in acute myocardial infarction. Chest 119(1 Suppl):253S–277S

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of recombinant human brain natriuretic peptide to improve ventricular function and hemodynamics in patients with ST-elevation myocardial infarction.;Investigación Clínica;2024-08-22

2. Letter by Chen et al Regarding Article, “STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial”;Circulation;2024-02-27

3. Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis;Thrombosis Research;2024-01

4. Reperfusion strategies in patients with ST-segment elevation myocardial infarction during hospitalization in China: Findings from the Improving Care for Cardiovascular disease in China (CCC)-Acute Cronary Synrome project;2023-12-11

5. Hemorrhagic stroke during the acute phase of myocardial infarction: a rare and difficult situation to manage;Radiology Case Reports;2023-03